Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Technology
History
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/84/56/f8/8456f856-ad25-ae40-93de-a1fc02233fe7/mza_17648738115460852203.jpg/600x600bb.jpg
Back Bay Life Science Report
Jonathan P. Gertler and Peter Bak
32 episodes
6 months ago
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.
Show more...
Medicine
Health & Fitness
RSS
All content for Back Bay Life Science Report is the property of Jonathan P. Gertler and Peter Bak and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.
Show more...
Medicine
Health & Fitness
https://img.transistor.fm/pYjK-qrqI6Iouki54aD6fOXFJdxowlHUXrvybxUGekA/rs:fill:3000:3000:1/q:60/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hYjU5/M2MyYzAxYzg3ODYz/MmYxMjdkN2NjMmM2/MjVkNy5qcGVn.jpg
Key Considerations for a US Healthcare IPO
Back Bay Life Science Report
35 minutes
1 year ago
Key Considerations for a US Healthcare IPO

In this DNB//Back Bay Healthcare Capital Markets podcast episode, learn about the key considerations, mechanics and timelines of going public on a US exchange.


 

 Topics in this podcast include: 

 

  • An overview of the decision-making process through execution for US-based and ex-US healthcare companies thinking about listing in the US
  • Core considerations after deciding to pursue a US listing and how to prepare most effectively
  • Building the “IPO advisory team”: types of advisors (legal, accounting, banking, IR firms, IP, etc.) and when to bring them in
  • Key documents and associated timelines related to the SEC documentation as well as investor outreach
  • What are the “don’ts” or mistakes companies make and how to avoid them

 

You can listen to previous episodes here or submit your inquiries here.

 

About our guests:

 

DNB//Back Bay is a committed partner throughout the healthcare development journey, addressing positioning, partnering, financing, M&A strategies, and listing support and execution on US and Nordic exchanges. Our team of more than 100 healthcare strategy and financial specialists spans the globe. Learn more about the DNB//Back Bay Partnership and read our disclaimers at https://www.bblsa.com/dnb-back-bay-partnership.


 

Cooley is among the top law firms for healthcare, tech and life science IPOs on both the issuer-side and underwriter-side. Their team of 1,300 lawyers is spread across 19 offices worldwide.

Back Bay Life Science Report
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.